PT  - JOURNAL ARTICLE
AU  - Clara Schulze
AU  - Josefina Durán
AU  - Rocío Bravo-Jeria
AU  - Francisca Verdugo-Paiva
AU  - Macarena Morel
AU  - Gabriel Rada
TI  - Therapeutic use of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis: Protocol for a systematic review
AID  - 10.1101/2020.07.25.20149922
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.25.20149922
4099  - http://medrxiv.org/content/early/2020/07/28/2020.07.25.20149922.short
4100  - http://medrxiv.org/content/early/2020/07/28/2020.07.25.20149922.full
AB  - OBJECTIVE To assess the therapeutic effects of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis.DESIGN This is the protocol of a systematic review. DATA SOURCES: Searches will be conducted in PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), trial registries, grey literature and in a centralized repository in L-OVE (Living OVerview of Evidence). L-OVE is a platform that maps PICO questions to evidence from Epistemonikos database.ELIGIBILITY CRITERIA FOR SELECTING STUDIES AND METHODS We will include randomized controlled trials evaluating therapeutic use of cannabis, cannabis-derived products and synthetic cannabinoids for rheumatoid arthritis. Our primary interest will be in trials comparing the intervention with placebo or no treatment (intervention plus optimal treatment vs placebo plus optimal treatment or optimal treatment alone) in patients receiving optimal treatment for rheumatoid arthritis. Optimal treatment will be defined as disease modifying anti-rheumatic drugs. Two reviewers will independently screen each study for eligibility, extract data, and assess the risk of bias. We will perform random-effects meta-analyses and use Grading of Recommendations Assessment, Development and Evaluation (GRADE) to assess the certainty of the evidence for each outcome.ETHICS AND DISSEMINATION The Scientific Ethics Committee of the Pontificia Universidad Católica de Chile granted ethical exemption for the realization of this study. Results of this review will be widely disseminated via peer-reviewed publications, social networks and traditional media and will be sent to relevant international organizations discussing this topic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was not commissioned by any organization and did not receive external funding. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Scientific Ethics Committee of the Pontificia Universidad Catolica de Chile granted ethical exemption for the realization of this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data related to the project will be available. Epistemonikos Foundation will grant access to data.